BV Financial, Inc. filings document the bank holding company's public-company reporting for BayVanguard Bank, including Form 8-K disclosures of operating results, balance-sheet trends, stock repurchase authorizations, executive departures and related compensation arrangements, and changes in the independent registered public accounting firm.
Proxy and meeting filings describe director elections, auditor ratification, stockholder voting results, board and audit committee matters, and governance procedures. The filings also identify BVFL common stock, its Nasdaq listing, and disclosure topics tied to deposits, loans, securities portfolios, borrowings, asset quality, credit-loss allowances, and capital management.
BV Financial, Inc. reported governance changes to its board leadership. The board elected Timothy L. Prindle as Chairman of the Board, in addition to his existing roles as President and Chief Executive Officer. The board cited his extensive knowledge of the company, leadership qualities, and strategic oversight as key reasons.
When the Chairman and CEO roles are combined, the independent directors expect to appoint a Lead Independent Director. Concurrently, the independent directors elected William B. Crompton, III as Lead Independent Director to provide strong independent perspectives, lead meetings of independent directors, and collaborate with the Chairman on board agendas.
BV Financial, Inc. (BVFL) lists a proposed sale by its director Joseph Galli of 21,500 common shares, with an aggregate market value of $423,765.00 and an approximate sale date of May 22, 2026. The shares are listed as coming from the FMT CO CUST IRA FBO Joseph S Galli account. The form also lists five earlier sales between February 28 and May 11, 2026.
BV Financial, Inc. director Joseph S. Galli filed an insider trading report showing an open-market sale of 3,404 shares of common stock held in an IRA at a weighted average price of $19.94, with trades between $19.90 and $20.04.
After this sale, the IRA held 24,674 shares, in addition to 80,309 directly held shares (including restricted stock) and 12,100 shares held through a retirement plan. Galli also holds stock options on 36,746 shares at an exercise price of $14.25 per share, vesting 25% annually beginning September 6, 2025 and expiring September 6, 2034.
BV Financial, Inc. director Joseph S. Galli reported selling a total of 2,027 shares of common stock on May 27, 2026 in three transactions at prices between $19.90 and $19.94, executed through an IRA.
After these trades, the IRA held 28,078 shares. Galli also reported 80,309 shares held directly, 12,100 shares held indirectly via a retirement plan, and stock options for 36,746 shares at an exercise price of $14.25 per share expiring on September 6, 2034; these restricted stock and option awards vest 25% per year starting September 6, 2025.
BV Financial, Inc. director Joseph S. Galli reported an open-market sale of 1,067 shares of common stock held indirectly through an IRA at $19.90 per share. After this sale, his IRA still holds 30,105 shares.
Galli also reports 80,309 direct shares, including restricted stock that vests 25% per year beginning on September 6, 2025, plus 12,100 shares held through a retirement plan. He further holds stock options covering 36,746 underlying shares at a $14.25 exercise price, expiring on September 6, 2034, vesting 25% annually from September 6, 2025.
BV Financial, Inc. director Joseph Galli gave notice of a proposed sale of 9,672 common shares, with an aggregate market value of $189,764.00 and an approximate sale date of May 26, 2026. The notice names Fidelity Brokerage Services LLC as broker and identifies FMT CO CUST IRA FBO Joseph Galli as the account from which the shares are to be sold.
BV Financial, Inc. director Joseph S. Galli reported a small open‑market sale of 169 shares of common stock at $20.00 per share through an IRA. After this transaction, he indirectly holds 31,172 common shares via the IRA and 12,100 common shares through a retirement plan, and directly holds 80,309 common shares.
His direct common stock holdings include restricted shares that vest 25% per year starting on September 6, 2025. Galli also holds stock options covering 34,746 underlying common shares with a $14.25 exercise price, expiring on September 6, 2034, which vest 25% per year beginning on the same date.
BV Financial, Inc. director Joseph S. Galli reported open-market sales of a total of 5,000 shares of common stock on May 8, 2026, executed through an IRA at prices of $20.03 and $20.00 per share. After these transactions, the IRA holds 31,341 shares, a retirement plan holds 12,100 shares, and he directly holds 80,309 shares of common stock. He also holds stock options tied to 36,746 underlying shares at an exercise price of $14.25 per share, expiring on September 6, 2034. Footnotes state that restricted stock and these options vest at a rate of 25% per year commencing on September 6, 2025.
BV Financial, Inc. director Joseph S. Galli reported open‑market sales of 5,000 shares of common stock. The trades, executed on May 7 2026 through an IRA, were priced around $20 per share, with individual prices ranging from $20.01 to $20.09.
After these transactions, Galli’s indirect IRA holding stands at 36,740 shares. He also indirectly holds 12,100 shares through a retirement plan and directly owns 80,309 shares of common stock, which include restricted stock that vests 25% per year starting on September 6 2025.
In addition, Galli holds stock options linked to 36,746 shares of common stock with a $14.25 exercise price, vesting 25% per year beginning September 6 2025 and expiring on September 6 2034. Overall, the filing shows a modest net sale while maintaining a substantial ongoing equity position.
BV Financial, Inc. reported lower profitability for the three months ended March 31, 2026. Net income was $1.1 million compared with $2.1 million a year earlier, and basic and diluted earnings per share were $0.13 versus $0.21. Total interest income edged up to $12.1 million, and net interest income rose to $9.1 million, helped by a small recovery of credit losses rather than an expense. However, noninterest expenses increased to $7.6 million, driven mainly by higher compensation and related benefits. At March 31, 2026, total assets were $910.9 million, loans totaled $735.6 million, and deposits were $673.5 million. Regulatory capital remained strong, with a Common Equity Tier 1 capital ratio of 21.27% and a Tier 1 leverage ratio of 16.81%.